Autonomix Medical, Inc. Common Stock
Autonomix Medical, Inc. Common Stock (AMIX) Stock Overview
Explore Autonomix Medical, Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.
AMIX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Autonomix Medical, Inc. Common Stock (AMIX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.20.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.16 and a market capitalization of 5.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
Bradley Hauser
5
21 Waterway Avenue, The Woodlands
2024